Contract award · 14 Apr 2025

NP34925g Anti-human T lymphocyte immunoglobulin (equine)

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") awarded “Anti-human T lymphocyte…” to Pfizer Ltd for £1.38m.

No competitionMedical equipment & pharmaceuticalsScotland

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Supplier
Pfizer Ltd
Value
£1,377,300
Procedure
Negotiated without publication of a contract notice
Sector
Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
Region
Scotland
Timeline
  1. Contract date14 Apr 2025
  2. Published14 Apr 2025Published the same day

Description

The Framework Agreement is for the supply of Anti-human T lymphocyte immunoglobulin (equine) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.

About the supplier

Other awards in the same procurement

Call-offs and awards published under the same process (for example a framework or dynamic purchasing system).

Date Contract Supplier Value
30 Apr 2025 Pfizer Ltd £1.4m

More from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

All contracts

More won by Pfizer Ltd

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview